Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.

Teal LB, Gould RW, Felts AS, Jones CK
Adv Pharmacol. 2019 86: 153-196

PMID: 31378251 · DOI:10.1016/bs.apha.2019.05.001

MeSH Terms (8)

Allosteric Regulation Animals Antipsychotic Agents Humans Receptors, Muscarinic Schizophrenia Signal Transduction Substance-Related Disorders

Connections (1)

This publication is referenced by other Labnodes entities: